Nuclear Medicine: Page 58

SNMMI: FDG-PET/MRI improves pain diagnosis, management

By Wayne Forrest

ANAHEIM, CA - By identifying increased metabolic activity or inflammation associated with chronic pain, FDG-PET/MRI can improve care management strategies for a majority of patients, according to a study presented Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 23, 2019

SNMMI: Technetium radiotracer tracks rheumatoid arthritis

By Brian Casey

ANAHEIM, CA - New findings on a technetium-based radiopharmaceutical that could be useful for monitoring rheumatoid arthritis by tracking joint inflammation were presented on Sunday at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) annual conference.

June 23, 2019

SNMMI: PET ligand can diagnose brain disorder before autopsy

By Wayne Forrest

ANAHEIM, CA - Researchers have developed a tau PET radioligand that can accurately differentiate in vivo between progressive supranuclear palsy and similar brain disorders, according to a study presented Saturday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 23, 2019

SNMMI: PSMA-PET helps guide prostate cancer therapy

By Wayne Forrest

ANAHEIM, CA - Adding an interim prostate-specific membrane antigen (PSMA)-PET scan during therapy can help guide treatment for patients with prostate cancer, according to a study presented Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 22, 2019

Sofie signs exclusive license for new FAPI radiotracers

By AuntMinnie.com staff writers

Molecular imaging developer Sofie Biosciences has signed an exclusive license agreement with University Hospital Heidelberg in Germany for a new class of radiopharmaceuticals that act as fibroblast activation protein inhibitors (FAPIs).

June 21, 2019

Fluke launches radiation measurement tool

By AuntMinnie.com staff writers

Fluke Biomedical is launching a new survey meter designed to provide radiation measurements with simplified data collection in a single tool for a variety of applications.

June 20, 2019

Shine validates isotope production process

By AuntMinnie.com staff writers

Medical isotope firm Shine Medical Technologies took another step toward medical isotope production with the recently completed validation of its low-enriched uranium process.

June 18, 2019

Jubilant forms new radiopharmaceutical company

By AuntMinnie.com staff writers

Jubilant Pharma has launched Jubilant Radiopharma, a new company that will bring its Jubilant DraxImage Radiopharmacies and Jubilant DraxImage radiopharmaceutical development businesses together under the umbrella of a single radiopharmaceutical brand.

June 18, 2019

Sofie Biosciences acquires Texas radiopharmacy

By AuntMinnie.com staff writers

Molecular imaging developer Sofie Biosciences has acquired Houston Cyclotron Partners, a cyclotron radiopharmacy based in Houston.

June 16, 2019

Blue Earth highlights SNMMI 2019 presentations

By AuntMinnie.com staff writers

Molecular imaging firm Blue Earth Diagnostics is touting 16 presentations involving its Axumin PET radiopharmaceutical and "radiohybrid" prostate-specific membrane antigen imaging agent at next week's Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 13, 2019

Navidea readies public stock offering

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals is planning to raise $6 million in a new public offering of its common stock.

June 13, 2019

ANSTO licensed to fully supply Mo-99

By AuntMinnie.com staff writers

The Australian Nuclear Science and Technology Organisation (ANSTO) has received a license to begin full production of molybdenum-99 (Mo-99) at its new nuclear facility.

June 11, 2019

Previous Page

Page 58 of 440

Next Page